Release Date: 06/03/18 18:39 Summary: Annual Report to Shareholders - 30 June 2016 Price Sensitive: No Download Document 2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%